Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Contemporary Clinical Trials
|
October 7, 2010
Toxicity equivalence range design (TEQR): a practical Phase I design
M Suzette Blanchard, Jeffrey A Longmate
The Journal of Biological Chemistry
|
June 16, 2009
The 3'-flap pocket of human flap endonuclease 1 is critical for substrate binding and catalysis
L David Finger, M Suzette Blanchard, Carla A Theimer, et al.
Cancer Gene Therapy
|
September 8, 2020
Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
Jana Portnow, Behnam Badie, M Suzette Blanchard, et al.
Blood Advances
|
September 7, 2021
CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma
Tanya Siddiqi, Xiuli Wang, M Suzette Blanchard, et al.
JAMA Oncology
|
October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
Jana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
The Oncologist
|
December 11, 2014
Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional age
Arti Hurria, M Suzette Blanchard, Timothy W Synold, et al.
Cancer Chemotherapy and Pharmacology
|
January 9, 2015
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine
Edward M Newman, Robert J Morgan, Shivaani Kummar, et al.
Journal of Geriatric Oncology
|
March 5, 2021
Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer
Yuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cell Reports. Medicine
|
August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety
Michael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Stem Cells Translational Medicine
|
September 10, 2013
Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use
Margarita Gutova, Joseph A Frank, Massimo D'Apuzzo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Contemporary Clinical Trials
|
October 7, 2010
Toxicity equivalence range design (TEQR): a practical Phase I design
M Suzette Blanchard, Jeffrey A Longmate
The Journal of Biological Chemistry
|
June 16, 2009
The 3'-flap pocket of human flap endonuclease 1 is critical for substrate binding and catalysis
L David Finger, M Suzette Blanchard, Carla A Theimer, et al.
Cancer Gene Therapy
|
September 8, 2020
Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
Jana Portnow, Behnam Badie, M Suzette Blanchard, et al.
Blood Advances
|
September 7, 2021
CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma
Tanya Siddiqi, Xiuli Wang, M Suzette Blanchard, et al.
JAMA Oncology
|
October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
Jana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
The Oncologist
|
December 11, 2014
Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional age
Arti Hurria, M Suzette Blanchard, Timothy W Synold, et al.
Cancer Chemotherapy and Pharmacology
|
January 9, 2015
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine
Edward M Newman, Robert J Morgan, Shivaani Kummar, et al.
Journal of Geriatric Oncology
|
March 5, 2021
Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer
Yuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cell Reports. Medicine
|
August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety
Michael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Stem Cells Translational Medicine
|
September 10, 2013
Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use
Margarita Gutova, Joseph A Frank, Massimo D'Apuzzo, et al.
Page
of 2